home All News open_in_new Full Article

Llega a España la combinación de Rybrevant y Lazcluze en primera línea para el CPNM avanzado con mutaciones en el EGFR

Llega a España la combinación de Rybrevant y Lazcluze en primera línea para el CPNM avanzado con mutaciones en el EGFR  El Globalfarma


today 37 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3058718777
Add Watch Country

arrow_drop_down